305 results on '"Natelson BH"'
Search Results
2. Analysis of cerebrospinal fluid from chronic fatigue syndrome patients for multiple human ubiquitous viruses and xenotropic murine leukemia-related virus.
- Author
-
Schutzer SE, Rounds MA, Natelson BH, Ecker DJ, and Eshoo MW
- Abstract
Recent reports showed many patients with chronic fatigue syndrome (CFS) harbor a retrovirus, xenotropic murine leukemia-related virus (XMRV), in blood; other studies could not replicate this finding. A useful next step would be to examine cerebrospinal fluid, because in some patients CFS is thought to be a brain disorder. Finding a microbe in the central nervous system would have greater significance than in blood because of the integrity of the blood-brain barrier. We examined cerebrospinal fluid from 43 CFS patients using polymerase chain reaction techniques, but did not find XMRV or multiple other common viruses, suggesting that exploration of other causes or pathogenetic mechanisms is warranted. Ann Neurol 2011; [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
3. Illness trajectories in the chronic fatigue syndrome: a longitudinal study of improvers versus non-improvers.
- Author
-
Ciccone DS, Chandler HK, and Natelson BH
- Published
- 2010
- Full Text
- View/download PDF
4. Clinical case update in fibromyalgia management.
- Author
-
Russell IJ, Natelson BH, Arnold LM, and Chou JC
- Published
- 2009
5. The influence of aerobic fitness and fibromyalgia on cardiorespiratory and perceptual responses to exercise in patients with chronic fatigue syndrome.
- Author
-
Cook DB, Nagelkirk PR, Poluri A, Mores J, and Natelson BH
- Abstract
OBJECTIVE: To investigate cardiorespiratory and perceptual responses to exercise in patients with chronic fatigue syndrome (CFS), accounting for comorbid fibromyalgia (FM) and controlling for aerobic fitness. METHODS: Twenty-nine patients with CFS only, 23 patients with CFS plus FM, and 32 controls completed an incremental bicycle test to exhaustion. Cardiorespiratory and perceptual responses were measured. Results were determined for the entire sample and for 18 subjects from each group matched for peak oxygen consumption. RESULTS: In the overall sample, there were no significant differences in cardiorespiratory parameters between the CFS only group and the controls. However, the CFS plus FM group exhibited lower ventilation, lower end-tidal CO2, and higher ventilatory equivalent of carbon dioxide compared with controls, and slower increases in heart rate compared with both patients with CFS only and controls. Peak oxygen consumption, ventilation, and workload were lower in the CFS plus FM group. Subjects in both the CFS only group and the CFS plus FM group rated exercise as more effortful than did controls. Patients with CFS plus FM rated exercise as significantly more painful than did patients with CFS only or controls. In the subgroups matched for aerobic fitness, there were no significant differences among the groups for any measured cardiorespiratory response, but perceptual differences in the CFS plus FM group remained. CONCLUSION: With matching for aerobic fitness, cardiorespiratory responses to exercise in patients with CFS only and CFS plus FM are not different from those in sedentary healthy subjects. While CFS patients with comorbid FM perceive exercise as more effortful and painful than do controls, those with CFS alone do not. These results suggest that aerobic fitness and a concurrent diagnosis of FM are likely explanations for currently conflicting data and challenge ideas implicating metabolic disease in the pathogenesis of CFS. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
6. Baroreceptor reflex and integrative stress responses in chronic fatigue syndrome.
- Author
-
Peckerman A, LaManca JJ, Qureishi B, Dahl KA, Golfetti R, Yamamoto Y, Natelson BH, Peckerman, Arnold, LaManca, John J, Qureishi, Bushra, Dahl, Kristina A, Golfetti, Roseli, Yamamoto, Yoshiharu, and Natelson, Benjamin H
- Published
- 2003
- Full Text
- View/download PDF
7. Functional status, neuropsychological functioning, and mood in chronic fatigue syndrome (CFS): relationship to psychiatric disorder.
- Author
-
Tiersky LA, Matheis RJ, Deluca J, Lange G, and Natelson BH
- Published
- 2003
- Full Text
- View/download PDF
8. Perceived exertion in fatiguing illness: civilians with chronic fatigue syndrome.
- Author
-
Cook DB, Nagelkirk PR, Peckerman A, Poluri A, LaManca JJ, and Natelson BH
- Published
- 2003
- Full Text
- View/download PDF
9. Perceived exertion in fatiguing illness: Gulf War veterans with chronic fatigue syndrome.
- Author
-
Cook DB, Nagelkirk PR, Peckerman A, Poluri A, LaManca JJ, and Natelson BH
- Published
- 2003
- Full Text
- View/download PDF
10. Comorbid illness in women with chronic fatigue syndrome: a test of the single syndrome hypothesis.
- Author
-
Ciccone DS, Natelson BH, Ciccone, Donald S, and Natelson, Benjamin H
- Published
- 2003
- Full Text
- View/download PDF
11. Stigma and chronic fatigue syndrome.
- Author
-
Green J, Romei J, and Natelson BH
- Abstract
We predicted that the largely female population seeking relief from the incapacitating symptoms of chronic fatigue syndrome (CFS), an enigmatic illness, would feel stigmatized, and that attribution of CFS symptoms to psychological causes by physicians would contribute significantly to the CFS-related stigma. Most subjects scored high on measures of stigma: 95% had feelings of estrangement, 70% believed that others attributed their CFS symptoms to psychological causes, 77% coped by using an educational strategy (disclosure) and 39% saw a need to be secretive about their symptoms in some circumstances. Most subjects (77%) were labeled as `psychological cases' by one or more of the physicians (mean = 8) consulted, but of the 4 stigma measures, only disclosure was related to physician labeling. Such factors as duration of illness and unemployment, dissatisfaction with spouse, and symptom severity correlated significantly with measures of stigma. That many physicians were reportedly ignorant or skeptical of CFS (male more so than female MD's) may influence attempts of CFS patients to legitimize their symptoms by disclosure and lead to high rates of health care system use. [ABSTRACT FROM AUTHOR]
- Published
- 1999
- Full Text
- View/download PDF
12. Physical, behavioral, and psychological risk factors for chronic fatigue syndrome: a central role for stress?
- Author
-
Dobbins JG, Natelson BH, Brassloff I, Drastal S, and Sisto S
- Abstract
In spite of the distinct epidemilogic features of chronic fatigue syndrome, its cause remains unknown and no risk factors for the illness have been identified. In order to better characterize CFS, we conducted a case-control study of well-defined CFS cases to identify physical, behavioral, and psychological factors related to the occurance of CFS . The study, conducted in the metropolitan area surrounding NEWARK, New Jersey, USA, included 20 patients who fulfilled the CFS definition and 20 matched controls. All subjects completed a self-administered questionnaire. The greatest difference between cases and controls was the reported level of stress from any of five sources in the 5 year period to onset of illness (95% vs. 55%: P = 0.011). In addition, the risk of CFS was significantly related to the number of sources of stress, especially three or more. Other significant risk factors included a history of premenstrual syndrome, a history of excema, loss of interest in daily activities, and panic attacks. Our results suggest that stress may be one of the factors related to the development of CFS. However, the possibility remains that the observed relationship resulted from a biased recollection of events preceding the illness. It is also possible that the perception of stress is correlated with some other variable related to the pathogenesis of CFS. [ABSTRACT FROM AUTHOR]
- Published
- 1995
- Full Text
- View/download PDF
13. Physical activity before and after exercise in women with chronic fatigue syndrome.
- Author
-
Sisto, SA, Tapp, WN, Lamanca, JJ, Ling, W, Korn, LR, Nelson, AJ, and Natelson, BH
- Published
- 1998
- Full Text
- View/download PDF
14. Psychiatric illnesses in Gulf War veterans.
- Author
-
Lange G and Natelson BH
- Published
- 2003
15. Effects of mental stress in patients with coronary artery disease: evidence and clinical implications.
- Author
-
Krantz DS, Sheps DS, Carney RM, Natelson BH, Jefferson TC, Krantz, D S, Sheps, D S, Carney, R M, and Natelson, B H
- Published
- 2000
- Full Text
- View/download PDF
16. Plasma 17-hydroxycorticosteroids and growth hormone during defense reactions
- Author
-
Natelson, BH, primary, Smith, GP, additional, Stokes, PE, additional, and Root, AW, additional
- Published
- 1974
- Full Text
- View/download PDF
17. Temporal changes in growth hormone, cortisol, and glucose: relation to light onset and behavior
- Author
-
Natelson, BH, primary, Holaday, J, additional, Meyerhoff, J, additional, and Stokes, PE, additional
- Published
- 1975
- Full Text
- View/download PDF
18. Changes of plasma glucose and insulin during defense reactions in monkeys
- Author
-
Natelson, BH, primary, Smith, GP, additional, Stokes, PE, additional, and Root, AW, additional
- Published
- 1973
- Full Text
- View/download PDF
19. The war-related illness and injury study centers: a resource for deployment-related health concerns.
- Author
-
Schneiderman AI, Lincoln AE, Helmer DA, Li M, Copeland HL, Prisco MK, Wallin MT, Kang HK, Natelson BH, Lincoln, Andrew E, Helmer, Drew A, Schneiderman, Aaron I, Li, Mian, Copeland, H Liesel, Prisco, Michelle K, Wallin, Mitchell T, Kang, Han K, and Natelson, Benjamin H
- Abstract
Combat veterans often return from deployment having experienced a wide range of exposures, symptoms, and medical conditions. The Department of Veterans Affairs established war-related illness and injury study centers to serve combat veterans with unexplained illnesses. We report the exposures, clinical status, and utilization of 53 combat veterans who participated in the National Referral Program (NRP) from January 2002 until March 2004. Participants were primarily male (81%) and served in the Persian Gulf War (79%). Common diagnoses were chronic fatigue syndrome (n = 23, 43%), neurotic depression (n = 21, 40%), and post-traumatic stress disorder (n = 20, 38%). Self-reported exposures related to weaponry, disease prophylaxis, environmental hazards, stress, and poor hygiene. A small increase in mean SF-36V mental component scores (2.8 points, p = 0.009) and use of rehabilitation therapies (1.6 additional visits, p = 0.018) followed the NRP referral. The small gain in mental function suggests that the NRP may benefit combat veterans with long and complex medical histories. [ABSTRACT FROM AUTHOR]
- Published
- 2006
20. Heterogeneity in Measures of Illness among Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Not Explained by Clinical Practice: A Study in Seven U.S. Specialty Clinics.
- Author
-
Unger ER, Lin JS, Chen Y, Cornelius ME, Helton B, Issa AN, Bertolli J, Klimas NG, Balbin EG, Bateman L, Lapp CW, Springs W, Podell RN, Fitzpatrick T, Peterson DL, Gottschalk CG, Natelson BH, Blate M, Kogelnik AM, Phan CC, and On Behalf Of The McAm Study Group
- Abstract
Background: One of the goals of the Multi-site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM) study was to evaluate whether clinicians experienced in diagnosing and caring for patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) recognized the same clinical entity. Methods: We enrolled participants from seven specialty clinics in the United States. We used baseline data (n = 465) on standardized questions measuring general clinical characteristics, functional impairment, post-exertional malaise, fatigue, sleep, neurocognitive/autonomic symptoms, pain, and other symptoms to evaluate whether patient characteristics differed by clinic. Results: We found few statistically significant and no clinically significant differences between clinics in their patients' standardized measures of ME/CFS symptoms and function. Strikingly, patients in each clinic sample and overall showed a wide distribution in all scores and measures. Conclusions: Illness heterogeneity may be an inherent feature of ME/CFS. Presenting research data in scatter plots or histograms will help clarify the challenge. Relying on case-control study designs without subgrouping or stratification of ME/CFS illness characteristics may limit the reproducibility of research findings and could obscure underlying mechanisms.
- Published
- 2024
- Full Text
- View/download PDF
21. Myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia are indistinguishable by their cerebrospinal fluid proteomes.
- Author
-
Schutzer SE, Liu T, Tsai CF, Petyuk VA, Schepmoes AA, Wang YT, Weitz KK, Bergquist J, Smith RD, and Natelson BH
- Subjects
- Humans, Proteome, Central Nervous System, Brain, Fatigue Syndrome, Chronic diagnosis, Fibromyalgia diagnosis
- Abstract
Background: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and fibromyalgia have overlapping neurologic symptoms particularly disabling fatigue. This has given rise to the question whether they are distinct central nervous system (CNS) entities or is one an extension of the other., Material and Methods: To investigate this, we used unbiased quantitative mass spectrometry-based proteomics to examine the most proximal fluid to the brain, cerebrospinal fluid (CSF). This was to ascertain if the proteome profile of one was the same or different from the other. We examined two separate groups of ME/CFS, one with ( n = 15) and one without ( n = 15) fibromyalgia., Results: We quantified a total of 2083 proteins using immunoaffinity depletion, tandem mass tag isobaric labelling and offline two-dimensional liquid chromatography coupled to tandem mass spectrometry, including 1789 that were quantified in all the CSF samples. ANOVA analysis did not yield any proteins with an adjusted p value <.05., Conclusion: This supports the notion that ME/CFS and fibromyalgia as currently defined are not distinct entities.Key messageME/CFS and fibromyalgia as currently defined are not distinct entities.Unbiased quantitative mass spectrometry-based proteomics can be used to discover cerebrospinal fluid proteins that are biomarkers for a condition such as we are studying.
- Published
- 2023
- Full Text
- View/download PDF
22. Natural killer cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a multi-site clinical assessment of ME/CFS (MCAM) sub-study.
- Author
-
Querec TD, Lin JS, Chen Y, Helton B, Kogelnik AM, Klimas NG, Peterson DL, Bateman L, Lapp C, Podell RN, Natelson BH, and Unger ER
- Subjects
- Humans, Killer Cells, Natural, CD146 Antigen, Fatigue Syndrome, Chronic, TRPM Cation Channels
- Abstract
Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multisystem illness characterized by substantial reduction in function accompanied by profound unexplained fatigue not significantly relieved by rest, post-exertional malaise, and other symptoms. Reduced natural killer (NK) cell count and cytotoxicity has been investigated as a biomarker for ME/CFS, but few clinical laboratories offer the test and multi-site verification studies have not been conducted., Methods: We determined NK cell counts and cytotoxicity in 174 (65%) ME/CFS, 86 (32%) healthy control (HC) and 10 (3.7%) participants with other fatigue associated conditions (ill control [IC]) from the Multi-Site Clinical Assessment of ME/CFS (MCAM) study using an assay validated for samples shipped overnight instead of testing on day of venipuncture., Results: We found a large variation in percent cytotoxicity [mean and (IQR) for ME/CFS and HC respectively, 34.1% (IQR 22.4-44.3%) and 33.6% (IQR 22.9-43.7%)] and no statistically significant differences between patients with ME/CFS and HC (p-value = 0.79). Analysis stratified on illness domain measured with standardized questionnaires did not identify an association of NK cytotoxicity with domain scores. Among all participants, NK cytotoxicity was not associated with survey results of physical and mental well-being, or health factors such as history of infection, obesity, smoking, and co-morbid conditions., Conclusion: These results indicate this assay is not ready for clinical implementation and studies are needed to further explore immune parameters that may be involved in the pathophysiology of ME/CFS., (© 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.)
- Published
- 2023
- Full Text
- View/download PDF
23. Assessing functional connectivity differences and work-related fatigue in surviving COVID-negative patients.
- Author
-
Hafiz R, Gandhi TK, Mishra S, Prasad A, Mahajan V, Natelson BH, Di X, and Biswal BB
- Abstract
The Coronavirus Disease 2019 (COVID-19) has affected all aspects of life around the world. Neuroimaging evidence suggests the novel coronavirus can attack the central nervous system (CNS), causing cerebro-vascular abnormalities in the brain. This can lead to focal changes in cerebral blood flow and metabolic oxygen consumption rate in the brain. However, the extent and spatial locations of brain alterations in COVID-19 survivors are largely unknown. In this study, we have assessed brain functional connectivity (FC) using resting-state functional MRI (RS-fMRI) in 38 (25 males) COVID patients two weeks after hospital discharge, when PCR negative and 31 (24 males) healthy subjects. FC was estimated using independent component analysis (ICA) and dual regression. When compared to the healthy group, the COVID group demonstrated significantly enhanced FC in the basal ganglia and precuneus networks ( family wise error ( fwe ) corrected, p
fwe < 0.05 ), while, on the other hand, reduced FC in the language network ( pfwe < 0.05 ). The COVID group also experienced higher fatigue levels during work, compared to the healthy group ( p < 0.001 ). Moreover, within the precuneus network, we noticed a significant negative correlation between FC and fatigue scores across groups ( Spearman's ρ = -0.47, p = 0.001, r2 = 0.22 ). Interestingly, this relationship was found to be significantly stronger among COVID survivors within the left parietal lobe , which is known to be structurally and functionally associated with fatigue in other neurological disorders., Competing Interests: Conflict of interest statement: The authors declare no competing financial interests.- Published
- 2023
- Full Text
- View/download PDF
24. Higher limbic and basal ganglia volumes in surviving COVID-negative patients and the relations to fatigue.
- Author
-
Hafiz R, Gandhi TK, Mishra S, Prasad A, Mahajan V, Di X, Natelson BH, and Biswal BB
- Abstract
Background: Among systemic abnormalities caused by the novel coronavirus, little is known about the critical attack on the central nervous system (CNS). Few studies have shown cerebrovascular pathologies that indicate CNS involvement in acute patients. However, replication studies are necessary to verify if these effects persist in COVID-19 survivors more conclusively. Furthermore, recent studies indicate fatigue is highly prevalent among 'long-COVID' patients. How morphometry in each group relate to work-related fatigue need to be investigated., Method: COVID survivors were MRI scanned two weeks after hospital discharge. We hypothesized, these survivors will demonstrate altered gray matter volume (GMV) and experience higher fatigue levels when compared to healthy controls, leading to stronger correlation of GMV with fatigue. Voxel-based morphometry was performed on T1-weighted MRI images between 46 survivors and 30 controls. Unpaired two-sample t -test and multiple linear regression were performed to observe group differences and correlation of fatigue with GMV., Results: The COVID group experienced significantly higher fatigue levels and GMV of this group was significantly higher within the Limbic System and Basal Ganglia when compared to healthy controls . Moreover, while a significant positive correlation was observed across the whole group between GMV and self-reported fatigue, COVID subjects showed stronger effects within the Posterior Cingulate , Precuneus and Superior Parietal Lobule ., Conclusion: Brain regions with GMV alterations in our analysis align with both single case acute patient reports and current group level neuroimaging findings. We also newly report a stronger positive correlation of GMV with fatigue among COVID survivors within brain regions associated with fatigue, indicating a link between structural abnormality and brain function in this cohort., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2022 The Authors. Published by Elsevier Inc.)
- Published
- 2022
- Full Text
- View/download PDF
25. Reply: CPET for Long COVID-19.
- Author
-
Mancini DM and Natelson BH
- Subjects
- Bacterial Toxins, Exercise Test, Humans, Oxygen Consumption, SARS-CoV-2, Post-Acute COVID-19 Syndrome, COVID-19 complications, Heart Failure
- Published
- 2022
- Full Text
- View/download PDF
26. Physiological assessment of orthostatic intolerance in chronic fatigue syndrome.
- Author
-
Natelson BH, Lin JS, Blate M, Khan S, Chen Y, and Unger ER
- Subjects
- Blood Pressure, Heart Rate, Humans, Quality of Life, Fatigue Syndrome, Chronic diagnosis, Orthostatic Intolerance diagnosis
- Abstract
Background: Orthostatic intolerance-OI is common in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-ME/CFS. We used a 10-min passive vertical lean test as orthostatic challenge-OC and measured changes in vitals and end tidal CO
2 (eTCO2). An abnormal physiologic response to OC was identified in 60% of the 63 patients evaluated from one to three times over several years. Hypocapnia, either resting or induced by OC, was the most frequent abnormality, followed by postural orthostatic tachycardia., Objective: Evaluate the physiologic response of patients with ME/CFS to a standardized OC., Design: Respiratory and heart rate, blood pressure and eTCO2 were recorded twice at the end of 10-min supine rest and then every minute during the 10-min lean. Hypocapnia was eTCO2 ≤ 32 mmHg. Orthostatic tachycardia was heart rate increase ≥ 30 beats per minute compared with resting or ≥ 120 BPM. Orthostatic hypotension was decreased systolic pressure ≥ 20 mmHg from baseline. Tachypnea was respiratory rate of ≥ 20 breaths per minute-either supine or leaning. Questionnaire data on symptom severity, quality of life and mood were collected at visit #2., Patients: 63 consecutive patients fulfilling the 1994 case definition for CFS underwent lean testing at first visit and then annually at visit 2 (n = 48) and 3 (n = 29)., Measures: Supine hypocapnia; orthostatic tachycardia, hypocapnia or hypotension., Results: The majority of ME/CFS patients (60.3%, 38/63) had an abnormality detected during a lean test at any visit (51%, 50% and 45% at visits 1, 2 and 3, respectively). Hypocapnia at rest or induced by OC was more common and more likely to persist than postural orthostatic tachycardia. Anxiety scores did not differ between those with and without hypocapnia., Conclusions: The 10-min lean test is useful in evaluation of OI in patients with ME/CFS. The most frequent abnormality, hypocapnia, would be missed without capnography., (© 2022. The Author(s).)- Published
- 2022
- Full Text
- View/download PDF
27. Use of Cardiopulmonary Stress Testing for Patients With Unexplained Dyspnea Post-Coronavirus Disease.
- Author
-
Mancini DM, Brunjes DL, Lala A, Trivieri MG, Contreras JP, and Natelson BH
- Subjects
- Adult, Dyspnea diagnosis, Dyspnea etiology, Exercise Test, Female, Humans, Male, Middle Aged, Oxygen Consumption, SARS-CoV-2, Stroke Volume, Ventricular Function, Left, COVID-19, Heart Failure
- Abstract
Objectives: The authors used cardiopulmonary exercise testing (CPET) to define unexplained dyspnea in patients with post-acute sequelae of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection (PASC). We assessed participants for criteria to diagnose myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)., Background: Approximately 20% of patients who recover from coronavirus disease (COVID) remain symptomatic. This syndrome is named PASC. Its etiology is unclear. Dyspnea is a frequent symptom., Methods: The authors performed CPET and symptom assessment for ME/CFS in 41 patients with PASC 8.9 ± 3.3 months after COVID. All patients had normal pulmonary function tests, chest X-ray, and chest computed tomography scans. Peak oxygen consumption (peak VO
2 ), slope of minute ventilation to CO2 production (VE/VCO2 slope), and end tidal pressure of CO2 (PetCO2 ) were measured. Ventilatory patterns were reviewed with dysfunctional breathing defined as rapid erratic breathing., Results: Eighteen men and 23 women (average age: 45 ± 13 years) were studied. Left ventricular ejection fraction was 59% ± 9%. Peak VO2 averaged 20.3 ± 7 mL/kg/min (77% ± 21% predicted VO2 ). VE/VCO2 slope was 30 ± 7. PetCO2 at rest was 33.5 ± 4.5 mm Hg. Twenty-four patients (58.5%) had a peak VO2 <80% predicted. All patients with peak VO2 <80% had a circulatory limitation to exercise. Fifteen of 17 patients with normal peak VO2 had ventilatory abnormalities including peak respiratory rate >55 (n = 3) or dysfunctional breathing (n = 12). For the whole cohort, 88% of patients (n = 36) had ventilatory abnormalities with dysfunctional breathing (n = 26), increased VE/VCO2 (n = 17), and/or hypocapnia PetCO2 <35 (n = 25). Nineteen patients (46%) met criteria for ME/CFS., Conclusions: Circulatory impairment, abnormal ventilatory pattern, and ME/CFS are common in patients with PASC. The dysfunctional breathing, resting hypocapnia, and ME/CFS may contribute to symptoms. CPET is a valuable tool to assess these patients., Competing Interests: Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
28. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management.
- Author
-
Bateman L, Bested AC, Bonilla HF, Chheda BV, Chu L, Curtin JM, Dempsey TT, Dimmock ME, Dowell TG, Felsenstein D, Kaufman DL, Klimas NG, Komaroff AL, Lapp CW, Levine SM, Montoya JG, Natelson BH, Peterson DL, Podell RN, Rey IR, Ruhoy IS, Vera-Nunez MA, and Yellman BP
- Subjects
- Adult, Attitude of Health Personnel, COVID-19 epidemiology, Fatigue Syndrome, Chronic diagnosis, Humans, Practice Patterns, Physicians', Family Practice standards, Fatigue Syndrome, Chronic therapy, Physician-Patient Relations
- Abstract
Despite myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) affecting millions of people worldwide, many clinicians lack the knowledge to appropriately diagnose or manage ME/CFS. Unfortunately, clinical guidance has been scarce, obsolete, or potentially harmful. Consequently, up to 91% of patients in the United States remain undiagnosed, and those diagnosed often receive inappropriate treatment. These problems are of increasing importance because after acute COVID-19, a significant percentage of people remain ill for many months with an illness similar to ME/CFS. In 2015, the US National Academy of Medicine published new evidence-based clinical diagnostic criteria that have been adopted by the US Centers for Disease Control and Prevention. Furthermore, the United States and other governments as well as major health care organizations have recently withdrawn graded exercise and cognitive-behavioral therapy as the treatment of choice for patients with ME/CFS. Recently, 21 clinicians specializing in ME/CFS convened to discuss best clinical practices for adults affected by ME/CFS. This article summarizes their top recommendations for generalist and specialist health care providers based on recent scientific progress and decades of clinical experience. There are many steps that clinicians can take to improve the health, function, and quality of life of those with ME/CFS, including those in whom ME/CFS develops after COVID-19. Patients with a lingering illness that follows acute COVID-19 who do not fully meet criteria for ME/CFS may also benefit from these approaches., (Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
29. Vagal nerve stimulation as a possible non-invasive treatment for chronic widespread pain in Gulf Veterans with Gulf War Illness.
- Author
-
Natelson BH, Stegner AJ, Lange G, Khan S, Blate M, Sotolongo A, DeLuca M, Van Doren WW, and Helmer DA
- Subjects
- Adult, Chronic Pain etiology, Double-Blind Method, Female, Humans, Male, Middle Aged, Persian Gulf Syndrome complications, Treatment Outcome, Vagus Nerve Stimulation adverse effects, Vagus Nerve Stimulation instrumentation, Veterans, Chronic Pain therapy, Persian Gulf Syndrome therapy, Vagus Nerve Stimulation methods
- Abstract
Aims: Widespread pain and headache are common in Gulf War Illness with suboptimal treatments available. We tested the efficacy of non-invasive, transcutaneous vagal nerve stimulation (nVNS) for relief of widespread pain and migraine in Gulf War Veterans with GWI., Main Methods: A 10-week double-blind, randomized controlled trial of nVNS used the gammaCore (ElectroCore, Inc.) compared to sham stimulation with the same device followed by a 10-week open-label follow up with active nVNS. The primary outcome was a numerical pain rating at the end of the blinded period. Secondary outcomes included physical function, migraine frequency and severity, and impression of change during the blinded and open-label periods. Two-factor MANOVA models tested for significant differences between groups from baseline to end of the blinded period and during the open-label period., Key Findings: Among 27 participants enrolled and issued a nVNS device, there was a slight improvement in pain ratings from baseline to the end of the blinded phase [6.18 (±0.82) vs. 5.05 (±2.3); p = 0.040] which did not differ between active and sham nVNS. Physical function was also slightly improved overall without group differences. There were no significant changes in migraine frequency or severity during the blinded period. Twenty participants started in the open-label phase; no statistically significant changes in pain, physical function, migraine measures, or impression of change were noted during this phase., Significance: Veterans with GWI actively treated with nVNS reported no improvement in either widespread pain or migraine frequency or severity relative to Veterans with GWI who received sham nVNS., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
30. Chronic Fatigue Syndrome and Cardiovascular Disease: JACC State-of-the-Art Review.
- Author
-
Natelson BH, Brunjes DL, and Mancini D
- Subjects
- Blood Pressure, Blood Volume, Fatigue Syndrome, Chronic physiopathology, Humans, Stroke Volume, Cardiovascular Diseases etiology, Fatigue Syndrome, Chronic complications, Orthostatic Intolerance etiology
- Abstract
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a medically unexplained illness characterized by severe fatigue limiting normal daily activities for at least 6 months accompanied by problems with unrefreshing sleep, exacerbation of symptoms following physical or mental efforts (postexertional malaise [PEM]), and either cognitive reports or physiological evidence of orthostatic intolerance in the form of either orthostatic tachycardia and/or hypocapnia. Although rarely considered to have cardiac dysfunction, ME/CFS patients frequently have reduced stroke volume with a significant inverse relation between cardiac output and PEM severity. Magnetic resonance imaging of ME/CFS patients compared with normal control subjects found significantly reduced stroke, end-systolic, and end-diastolic volumes together with reduced end-diastolic wall mass. Another cardiovascular abnormality is reduced nocturnal blood pressure assessed by 24-hour monitoring. Autonomic dysfunction is also frequently observed with postural orthostatic tachycardia and/or hypocapnia. Two consecutive cardiopulmonary stress tests may provide metabolic data substantiating PEM., Competing Interests: Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
31. The effect of comorbid medical and psychiatric diagnoses on chronic fatigue syndrome.
- Author
-
Natelson BH, Lin JS, Lange G, Khan S, Stegner A, and Unger ER
- Subjects
- Adult, Comorbidity, Fatigue Syndrome, Chronic psychology, Female, Humans, Male, Middle Aged, New York City epidemiology, Fatigue Syndrome, Chronic epidemiology, Mental Disorders epidemiology
- Abstract
Objective: To determine if presence of co-existing medically unexplained syndromes or psychiatric diagnoses affect symptom frequency, severity or activity impairment in Chronic Fatigue Syndrome. Patients: Sequential Chronic Fatigue Syndrome patients presenting in one clinical practice. Design: Participants underwent a psychiatric diagnostic interview and were evaluated for fibromyalgia, irritable bowel syndrome and/or multiple chemical sensitivity. Main Measures: Structured Clinical Interview [SCID] for DSM-IV; SF-36, Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Short Form; Patient Health Questionnaire-8; Multidimensional Fatigue Inventory (MFI-20), CDC Symptom Inventory Results: Current and lifetime psychiatric diagnosis was common (68%) increasing mental fatigue/health but no other illness variables and not with diagnosis of other medically unexplained syndromes. 81% of patients had at least one of these conditions with about a third having all three co-existing syndromes. Psychiatric diagnosis was not associated with their diagnosis. Increasing the number of these unexplained conditions was associated with increasing impairment in physical function, pain and rates of being unable to work. Conclusions: Patients with Chronic Fatigue Syndrome should be evaluated for current psychiatric conditions because of their impact on patient quality of life, but they do not act as a symptom multiplier for the illness. Other co-existing medically unexplained syndromes are more common than psychiatric co-morbidities in patients presenting for evaluation of medically unexplained fatigue and are also more associated with increased disability and the number and severity of symptoms.Key messagesWhen physicians see patients with medically unexplained fatigue, they often infer that this illness is due to an underlying psychiatric problem.This paper shows that the presence of co-existing psychiatric diagnoses does not impact on any aspect of the phenomenology of medically unexplained fatigue also known as chronic fatigue syndrome. Therefore, psychiatric status is not an important causal contributor to CFS.In contrast, the presence of other medically unexplained syndromes (irritable bowel syndrome; fibromyalgia and/or multiple chemical sensitivity) do impact on the illness such that the more of these that co-exist the more health-related burdens the patient has.
- Published
- 2019
- Full Text
- View/download PDF
32. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: Definitions, Similarities, and Differences.
- Author
-
Natelson BH
- Subjects
- Humans, Fatigue Syndrome, Chronic diagnosis, Fibromyalgia diagnosis
- Abstract
This commentary presents a simplified way of making the diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) using the 1994 Centers for Disease Control and Prevention case definition. The format used can easily be modified for other case definitions. The commentary then discusses whether ME/CFS is the same or a different illness from fibromyalgia. Because overlap exists between the 2 syndromes, some investigators have posited that they are variants of the same illness. I have viewed this as an empirically testable hypothesis and have summoned considerable amounts of data that suggest that the 2 illnesses differ. Were differences to exist, that would suggest different pathophysiologic processes for each, leading to different treatments., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
33. Balance deficits in Chronic Fatigue Syndrome with and without fibromyalgia.
- Author
-
Serrador JM, Quigley KS, Zhao C, Findley T, and Natelson BH
- Subjects
- Adult, Fatigue Syndrome, Chronic complications, Female, Fibromyalgia complications, Humans, Male, Middle Aged, Fatigue Syndrome, Chronic physiopathology, Fibromyalgia physiopathology, Postural Balance
- Abstract
Objective: Chronic Fatigue Syndrome (CFS) is a disorder of unknown etiology associated with debilitating fatigue. One symptom commonly reported is disequilibrium. The goal of this study was to determine if CFS patients demonstrated verified balance deficits and if this was effected by comorbid fibromyalgia (FM)., Methods: Twenty-seven patients with CFS (12 with comorbid FM) and 22 age and gender matched controls performed posturography., Results: Balance scores were significantly correlated with physical functional status in the CFS group (R2 = 0.43, P < 0.001), which was not found for mental functional status (R2 = 0.06, P > 0.5). CFS patients (regardless of FM) had significantly higher anxiety subscale of the vertigo symptom scale scores. CFS patients, regardless of FM status, demonstrated significantly lower overall composite balance scores (Controls - 78.8±1.5; CFS - 69.0±1.4, P < 0.005) even when controlling for anxiety and also had worse preference scores, indicating they relied on visual information preferentially even when visual information was incorrect. Interestingly, the CFS+FM group, not CFS only, demonstrated significantly worse vestibular scores (Controls - 70.2±2.4; CFS only - 67.9±3.8; CFS with FM - 55.4±4.6, P = 0.013)., Interpretation: The major findings are that poor balance may be associated with poorer self-reported physical health. In addition, CFS patients seemed to rely preferentially on visual inputs, regardless of whether it was correct. The finding that vestibular function may be impaired in patients with CFS+FM but not in those with CFS alone suggests that the pathophysiology of CFS+FM may differ as has been suggested by some.
- Published
- 2018
- Full Text
- View/download PDF
34. Multimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity.
- Author
-
Natelson BH, Mao X, Stegner AJ, Lange G, Vu D, Blate M, Kang G, Soto E, Kapusuz T, and Shungu DC
- Subjects
- Adult, Analysis of Variance, Cerebrovascular Circulation physiology, Cohort Studies, Female, Glutathione metabolism, Humans, Lactic Acid cerebrospinal fluid, Magnetic Resonance Spectroscopy, Male, Middle Aged, Neuropsychological Tests, Psychiatric Status Rating Scales, Brain pathology, Fatigue Syndrome, Chronic cerebrospinal fluid, Fatigue Syndrome, Chronic diagnostic imaging, Fatigue Syndrome, Chronic epidemiology, Fatigue Syndrome, Chronic pathology, Mental Disorders cerebrospinal fluid, Mental Disorders diagnostic imaging, Mental Disorders epidemiology, Mental Disorders pathology
- Abstract
The purpose of this study was to investigate whether CFS patients without comorbid psychiatric diagnoses differ from CFS patients with comorbid psychiatric diagnoses and healthy control subjects in neuropsychological performance, the proportion with elevated spinal fluid protein or white cell counts, cerebral blood flow (CBF), brain ventricular lactate and cortical glutathione (GSH). The results of the study did not show any differences in any of the outcome measures between CFS patients with and without psychiatric comorbidity, thus indicating that psychiatric status may not be an exacerbating factor in CFS. Importantly, significant differences were found between the pooled samples of CFS compared to controls. These included lower GSH and CBF and higher ventricular lactate and rates of spinal fluid abnormalities in CFS patients compared to healthy controls. Thirteen of 26 patients had abnormal values on two or more of these 4 brain-related variables. These findings, which replicate the results of several of our prior studies, support the presence of a number of neurobiological and spinal fluid abnormalities in CFS. These results will lead to further investigation into objective biomarkers of the disorder to advance the understanding of CFS., (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
35. Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.
- Author
-
Unger ER, Lin JS, Tian H, Natelson BH, Lange G, Vu D, Blate M, Klimas NG, Balbin EG, Bateman L, Allen A, Lapp CW, Springs W, Kogelnik AM, Phan CC, Danver J, Podell RN, Fitzpatrick T, Peterson DL, Gottschalk CG, and Rajeevan MS
- Subjects
- Adolescent, Adult, Disease Progression, Fatigue Syndrome, Chronic epidemiology, Fatigue Syndrome, Chronic pathology, Fatigue Syndrome, Chronic therapy, Female, Humans, Hydrocortisone analysis, Male, Middle Aged, Prospective Studies, Research Design, Retrospective Studies, Saliva chemistry, Surveys and Questionnaires, United States epidemiology, Young Adult, Fatigue Syndrome, Chronic diagnosis
- Abstract
In the Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM), we relied on expert clinician diagnoses to enroll patients from 7 specialty clinics in the United States in order to perform a systematic collection of data on measures of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS). Healthy persons and those with other illnesses that share some features with ME/CFS were enrolled in comparison groups. The major objectives were to: 1) use standardized questionnaires to measure illness domains of ME/CFS and to evaluate patient heterogeneity overall and between clinics; 2) describe the course of illness, identify the measures that best correlate with meaningful clinical differences, and assess the performances of questionnaires as patient/person-reported outcome measures; 3) describe prescribed medications, orders for laboratory and other tests, and management tools used by expert clinicians to care for persons with ME/CFS; 4) collect biospecimens for future hypothesis testing and for evaluation of morning cortisol profiles; and 5) identify measures that best distinguish persons with ME/CFS from those in the comparison groups and detect subgroups of persons with ME/CFS who may have different underlying causes. Enrollment began in 2012 and is planned to continue in multiple stages through 2017. We present the MCAM methods in detail, along with an initial description of the 471 patients with ME/CFS who were enrolled in stage 1., (Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.)
- Published
- 2017
- Full Text
- View/download PDF
36. Sleep continuity is positively correlated with sleep duration in laboratory nighttime sleep recordings.
- Author
-
Kishi A, Van Dongen HP, Natelson BH, Bender AM, Palombini LO, Bittencourt L, Tufik S, Ayappa I, and Rapoport DM
- Subjects
- Adult, Aged, Aged, 80 and over, Cohort Studies, Continuous Positive Airway Pressure, Datasets as Topic, Fatigue, Female, Humans, Male, Middle Aged, Polysomnography, Sleep Apnea, Obstructive physiopathology, Sleep Apnea, Obstructive therapy, Survival Analysis, Time Factors, Wakefulness, Young Adult, Sleep
- Abstract
Sleep duration varies widely across individuals and appears to be trait-like. Differences in the stability of underlying sleep processes may underlie this phenomenon. To investigate underlying mechanisms, we examined the relationship between sleep duration and sleep continuity in baseline polysomnography (PSG) recordings from three independently collected datasets: 1) 134 healthy controls (ages 37 ± 13 years) from the São Paulo Epidemiologic Sleep Study, who spent one night in a sleep laboratory, 2) 21 obstructive sleep apnea (OSA) patients who were treated with continuous positive airway pressure for at least 2 months (45 ± 12 years, respiratory disturbance index <15), who spent one night in a sleep laboratory with previous experience of multiple PSG studies, and 3) 62 healthy controls (28 ± 6 years) who, as part of larger experiments, spent 2 consecutive nights in a sleep laboratory. For each dataset, we used total sleep time (TST) to separate subjects into those with shorter sleep (S-TST) and those with longer sleep (L-TST). In all three datasets, survival curves of continuous sleep segments showed greater sleep continuity in L-TST than in S-TST. Correlation analyses with TST as a continuous variable corroborated the results; and the results also held true after controlling for age. There were no significant differences in baseline waking performance and sleepiness between S-TST and L-TST. In conclusion, in both healthy controls and treated OSA patients, sleep continuity was positively correlated with sleep duration. These findings suggest that S-TST may differ from L-TST in processes underlying sleep continuity, shedding new light on mechanisms underlying individual differences in sleep duration.
- Published
- 2017
- Full Text
- View/download PDF
37. Elevations of Ventricular Lactate Levels Occur in Both Chronic Fatigue Syndrome and Fibromyalgia.
- Author
-
Natelson BH, Vu D, Coplan JD, Mao X, Blate M, Kang G, Soto E, Kapusuz T, and Shungu DC
- Abstract
Background: Chronic fatigue syndrome (CFS) and fibromyalgia (FM) frequently have overlapping symptoms, leading to the suggestion that the same disease processes may underpin the two disorders - the unitary hypothesis. However, studies investigating the two disorders have reported substantial clinical and/or biological differences between them, suggesting distinct pathophysiological underpinnings., Purpose: The purpose of this study was to further add to the body of evidence favoring different disease processes in CFS and FM by comparing ventricular cerebrospinal fluid lactate levels among patients with CFS alone, FM alone, overlapping CFS and FM symptoms, and healthy control subjects., Methods: Ventricular lactate was assessed in vivo with proton magnetic resonance spectroscopic imaging (
1 H MRSI) with the results normed across the 2 studies in which the data were collected., Results: Mean CSF lactate levels in CFS, FM and CFS+FM did not differ among the three groups, but were all significantly higher than the mean values for control subjects., Conclusion: While patients with CFS, FM and comorbid CFS and FM can be differentiated from healthy subjects based on measures of CFS lactate, this neuroimaging outcome measure is not a viable biomarker for differentiating CFS from FM or from patients in whom symptoms of the two disorders overlap.- Published
- 2017
- Full Text
- View/download PDF
38. Comparison of the functional health limitations of Iraq or Afghanistan Veterans to Desert Shield/Storm Veterans with chronic fatigue syndrome.
- Author
-
McAndrew LM, Chandler HK, Serrador JM, Quigley KS, Natelson BH, and Lange G
- Abstract
Initial evidence suggests some Operation Enduring/Iraqi Freedom (OEF/OIF) veterans suffer from significant physical symptoms. It is not known if other medical conditions may explain these symptoms or if they are causing functional limitations. We compared OEF/OIF veterans with CFS to Desert Shield/Storm veterans with CFS seen at a post-deployment VA clinic soon after their respective deployments. We found 17.6% of OEF/OIF veterans met criteria for CFS. Compared to Desert Shield/Storm veterans with CFS, the OEF/OIF veterans with CFS demonstrated worse mental health function and similar physical health function.
- Published
- 2016
- Full Text
- View/download PDF
39. Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial.
- Author
-
Natelson BH, Vu D, Mao X, Weiduschat N, Togo F, Lange G, Blate M, Kang G, Coplan JD, and Shungu DC
- Subjects
- Adrenergic Uptake Inhibitors therapeutic use, Adult, Attention drug effects, Biomarkers metabolism, Cerebral Ventricles metabolism, Double-Blind Method, Executive Function drug effects, Female, Fibromyalgia physiopathology, Fibromyalgia psychology, Humans, Middle Aged, Milnacipran, Nonlinear Dynamics, Pain physiopathology, Pain Measurement, Proton Magnetic Resonance Spectroscopy, Psychological Tests, Selective Serotonin Reuptake Inhibitors therapeutic use, Anti-Inflammatory Agents, Non-Steroidal therapeutic use, Cerebral Ventricles drug effects, Cyclopropanes therapeutic use, Fibromyalgia drug therapy, Lactic Acid metabolism, Pain drug therapy
- Abstract
Unlabelled: Milnacipran, a serotonin/norepinephrine reuptake inhibitor, has been approved by the US Food and Drug Administration for the treatment of fibromyalgia (FM). This report presents the results of a randomized, double-blind, placebo-controlled trial of milnacipran conducted to test the hypotheses that a) similar to patients with chronic fatigue syndrome, patients with FM have increased ventricular lactate levels at baseline; b) 8 weeks of treatment with milnacipran will lower ventricular lactate levels compared with baseline levels and with ventricular lactate levels after placebo; and c) treatment with milnacipran will improve attention and executive function in the Attention Network Test compared with placebo. In addition, we examined the results for potential associations between ventricular lactate and pain. Baseline ventricular lactate measured by proton magnetic resonance spectroscopic imaging was found to be higher in patients with FM than in healthy controls (F1,37 = 22.11, P < .0001, partial η(2) = .37). Milnacipran reduced pain in patients with FM relative to placebo but had no effect on cognitive processing. At the end of the study, ventricular lactate levels in the milnacipran-treated group had decreased significantly compared with baseline and after placebo (F1,18 = 8.18, P = .01, partial η(2) = .31). A significantly larger proportion of patients treated with milnacipran showed decreases in both ventricular lactate and pain than those treated with placebo (P = .03). These results suggest that proton magnetic resonance spectroscopic imaging measurements of lactate may serve as a potential biomarker for a therapeutic response in FM and that milnacipran may act, at least in part, by targeting the brain response to glial activation and neuroinflammation., Perspective: Patients treated with milnacipran showed decreases in both pain and ventricular lactate levels compared with those treated with placebo, but, even after treatment, levels of ventricular lactate remained higher than in controls. The hypothesized mechanism for these decreases is via drug-induced reductions of a central inflammatory state., (Copyright © 2015 American Pain Society. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
40. Chronic fatigue syndrome and fibromyalgia in diagnosed sleep disorders: a further test of the 'unitary' hypothesis.
- Author
-
Pejovic S, Natelson BH, Basta M, Fernandez-Mendoza J, Mahr F, and Vgontzas AN
- Subjects
- Adult, Comorbidity, Female, Health Services, Humans, Irritable Bowel Syndrome epidemiology, Male, Middle Aged, Sleep, Sleep Stages, Sleep Wake Disorders epidemiology, Surveys and Questionnaires, Depression epidemiology, Fatigue Syndrome, Chronic epidemiology, Fibromyalgia epidemiology, Sleep Apnea Syndromes epidemiology, Sleep Initiation and Maintenance Disorders epidemiology
- Abstract
Background: Since chronic fatigue syndrome (CFS) and fibromyalgia (FM) often co-exist, some believe they reflect the same process, somatization. Against that hypothesis are data suggesting FM but not CFS was common in patients with sleep-disordered breathing (SDB). The presence of discrete case definitions for CFS and FM allowed us to explore rates of CFS alone, CFS with FM, and FM alone in SDB patients compared to those with sleep complaints that fulfilled criteria for insomnia., Methods: Participants were 175 sequential patients with sleep-related symptoms (122 had SDB and 21 had insomnia) and 39 healthy controls. Diagnoses were made by questionnaires, tender point count, and rule out labs; sleepiness was assessed with Epworth Sleepiness Scale and mood with Beck Depression Inventory., Results: Rates of CFS, FM or CFS + FM were high: 13% in SDB and 48% in insomnia. CFS occurred frequently in SDB and insomnia, but FM occurred frequently only in insomnia. SDB patients with CFS and/or FM had higher daytime sleepiness than those without these disorders., Conclusion: CFS patients should complete Epworth scales, and sleep evaluation should be considered for those with scores ≥ 16 before receiving the diagnosis of CFS; the coexistence of depressed mood in these patients suggests some may be helped by treatment of their depression. That FM was underrepresented in SDB suggests FM and CFS may have different underlying pathophysiological causes.
- Published
- 2015
- Full Text
- View/download PDF
41. Attention network test: assessment of cognitive function in chronic fatigue syndrome.
- Author
-
Togo F, Lange G, Natelson BH, and Quigley KS
- Subjects
- Adult, Case-Control Studies, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Reaction Time physiology, Young Adult, Attention physiology, Cognition Disorders diagnosis, Cognition Disorders etiology, Fatigue Syndrome, Chronic complications
- Abstract
Information processing difficulties are common in patients with chronic fatigue syndrome (CFS). It has been shown that the time it takes to process a complex cognitive task, rather than error rate, may be the critical variable underlying CFS patients' cognitive complaints. The Attention Network Task (ANT) developed by Fan and colleagues may be of clinical utility to assess cognitive function in CFS, because it allows for simultaneous assessment of mental response speed, also called information processing speed, and error rate under three conditions challenging the attention system. Comparison of data from two groups of CFS patients (those with and without comorbid major depressive disorder; n = 19 and 22, respectively) to controls (n = 29) consistently showed that error rates did not differ among groups across conditions, but speed of information processing did. Processing time was prolonged in both CFS groups and most significantly affected in response to the most complex task conditions. For simpler tasks, processing time was only prolonged in CFS participants with depression. The data suggest that the ANT may be a task that could be used clinically to assess information processing deficits in individuals with CFS., (© 2013 The British Psychological Society.)
- Published
- 2015
- Full Text
- View/download PDF
42. The effects of exercise on dynamic sleep morphology in healthy controls and patients with chronic fatigue syndrome.
- Author
-
Kishi A, Togo F, Cook DB, Klapholz M, Yamamoto Y, Rapoport DM, and Natelson BH
- Abstract
Effects of exercise on dynamic aspects of sleep have not been studied. We hypothesized exercise altered dynamic sleep morphology differently for healthy controls relative to chronic fatigue syndrome (CFS) patients. Sixteen controls (38 ± 9 years) and 17 CFS patients (41 ± 8 years) underwent polysomnography on baseline nights and nights after maximal exercise testing. We calculated transition probabilities and rates (as a measure of relative and temporal transition frequency, respectively) between sleep stages and cumulative duration distributions (as a measure of continuity) of each sleep stage and sleep as a whole. After exercise, controls showed a significantly greater probability of transition from N1 to N2 and a lower rate of transition from N1 to wake than at baseline; CFS showed a significantly greater probability of transition from N2 to N3 and a lower rate of transition from N2 to N1. These findings suggest improved quality of sleep after exercise. After exercise, controls had improved sleep continuity, whereas CFS had less continuous N1 and more continuous rapid eye movement (REM) sleep. However, CFS had a significantly greater probability and rate of transition from REM to wake than controls. Probability of transition from REM to wake correlated significantly with increases in subjective fatigue, pain, and sleepiness overnight in CFS - suggesting these transitions may relate to patient complaints of unrefreshing sleep. Thus, exercise promoted transitions to deeper sleep stages and inhibited transitions to lighter sleep stages for controls and CFS, but CFS also reported increased fatigue and continued to have REM sleep disruption. This dissociation suggests possible mechanistic pathways for the underlying pathology of CFS.
- Published
- 2013
- Full Text
- View/download PDF
43. Exercise and sleep deprivation do not change cytokine expression levels in patients with chronic fatigue syndrome.
- Author
-
Nakamura T, Schwander S, Donnelly R, Cook DB, Ortega F, Togo F, Yamamoto Y, Cherniack NS, Klapholz M, Rapoport D, and Natelson BH
- Subjects
- Adult, Female, Humans, Middle Aged, Cytokines blood, Exercise, Fatigue Syndrome, Chronic immunology, Sleep Deprivation immunology
- Abstract
A major hypothesis regarding the cause of chronic fatigue syndrome (CFS) is immune dysregulation, thought to be reflected in upregulated proinflammatory cytokines leading to the symptoms that are characteristic of this illness. Because the symptoms worsen with physical exertion or sleep loss, we hypothesized that we could use these stressors to magnify the underlying potential pathogenic abnormalities in the cytokine systems of people with CFS. We conducted repeat blood sampling for cytokine levels from healthy subjects and CFS patients during both postexercise and total sleep deprivation nights and assayed for protein levels in the blood samples, mRNA activity in peripheral blood lymphocytes (PBLs), and function in resting and stimulated PBLs. We found that these environmental manipulations did not produce clinically significant upregulation of proinflammatory cytokines. These data do not support an important role of immune dysregulation in the genesis of stress-induced worsening of CFS.
- Published
- 2013
- Full Text
- View/download PDF
44. Heart rate variability during sleep and subsequent sleepiness in patients with chronic fatigue syndrome.
- Author
-
Togo F and Natelson BH
- Subjects
- Adult, Fatigue Syndrome, Chronic diagnosis, Fatigue Syndrome, Chronic epidemiology, Female, Humans, Middle Aged, Polysomnography methods, Sleep physiology, Sleep Deprivation diagnosis, Sleep Deprivation epidemiology, Fatigue Syndrome, Chronic physiopathology, Heart Rate physiology, Sleep Deprivation physiopathology, Sleep Stages physiology
- Abstract
We determined whether alterations in heart rate dynamics during sleep in patients with chronic fatigue syndrome (CFS) differed from controls and/or correlated with changes of sleepiness before and after a night in the sleep laboratory. We compared beat-to-beat RR intervals (RRI) during nocturnal sleep, sleep structure, and subjective scores on visual analog scale for sleepiness in 18 CFS patients with 19 healthy controls aged 25-55 after excluding subjects with sleep disorders. A short-term fractal scaling exponent (α1) of RRI dynamics, analyzed by the detrended fluctuation analysis (DFA) method, was assessed after stratifying patients into those who reported more or less sleepiness after the night's sleep (a.m. sleepier or a.m. less sleepy, respectively). Patients in the a.m. sleepier group showed significantly (p<0.05) higher fractal scaling index α1 during non-rapid eye movement (non-REM) sleep (Stages 1, 2, and 3 sleep) than healthy controls, although standard polysomnographic measures did not differ between the groups. The fractal scaling index α1 during non-REM sleep was significantly (p<0.05) higher than that during awake periods after sleep onset for healthy controls and patients in the a.m. less sleepy group, but did not differ between sleep stages for patients in the a.m. sleepier group. For patients, changes in self-reported sleepiness before and after the night correlated positively with the fractal scaling index α1 during non-REM sleep (p<0.05). These results suggest that RRI dynamics or autonomic nervous system activity during non-REM sleep might be associated with disrupted sleep in patients with CFS., (Copyright © 2013 Elsevier B.V. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
45. Brain dysfunction as one cause of CFS symptoms including difficulty with attention and concentration.
- Author
-
Natelson BH
- Abstract
We have been able to reduce substantially patient pool heterogeneity by identifying phenotypic markers that allow the researcher to stratify chronic fatigue syndrome (CFS) patients into subgroups. To date, we have shown that stratifying based on the presence or absence of comorbid psychiatric diagnosis leads to a group with evidence of neurological dysfunction across a number of spheres. We have also found that stratifying based on the presence or absence of comorbid fibromyalgia leads to information that would not have been found on analyzing the entire, unstratified patient group. Objective evidence of orthostatic intolerance (OI) may be another important variable for stratification and may define a group with episodic cerebral hypoxia leading to symptoms. We hope that this review will encourage other researchers to collect data on discrete phenotypes in CFS to allow this work to continue more broadly. Finding subgroups of CFS suggests different underlying pathophysiological processes responsible for the symptoms seen. Understanding those processes is the first step toward developing discrete treatments for each.
- Published
- 2013
- Full Text
- View/download PDF
46. Is chronic fatigue syndrome the same illness as fibromyalgia: evaluating the 'single syndrome' hypothesis.
- Author
-
Abbi B and Natelson BH
- Subjects
- Biomarkers blood, Diagnosis, Differential, Fatigue Syndrome, Chronic blood, Fatigue Syndrome, Chronic classification, Fibromyalgia blood, Fibromyalgia classification, Hormones blood, Humans, Syndrome, Fatigue Syndrome, Chronic diagnosis, Fibromyalgia diagnosis
- Abstract
Chronic fatigue syndrome (CFS) and fibromyalgia (FM) are medically unexplained syndromes that can and often do co-occur. For this reason, some have posited that the two are part of the same somatic syndrome--examples of symptom amplification. This hypothesis would suggest that few differences exist between the two syndromes. To evaluate this interpretation, we have searched the literature for articles comparing CFS to FM, reviewing only those articles which report differences between the two. This review presents data showing differences across a number of parameters--implying that the underlying pathophysiology in CFS may differ from that of FM. We hope that our review encourages other groups to look for additional differences between CFS and FM. By continuing to preserve the unique illness definitions of the two syndromes, clinicians will be able to better identify, understand and provide treatment for these individuals.
- Published
- 2013
- Full Text
- View/download PDF
47. Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology.
- Author
-
Shungu DC, Weiduschat N, Murrough JW, Mao X, Pillemer S, Dyke JP, Medow MS, Natelson BH, Stewart JM, and Mathew SJ
- Subjects
- Adolescent, Adult, Cerebral Cortex blood supply, Cerebral Cortex pathology, Cerebral Cortex physiopathology, Cerebral Ventricles blood supply, Cerebral Ventricles pathology, Cerebral Ventricles physiopathology, Cerebrovascular Circulation physiology, Demography, Fatigue Syndrome, Chronic pathology, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Occipital Lobe metabolism, Occipital Lobe physiopathology, Organ Size, Phosphates metabolism, Regional Blood Flow physiology, Spin Labels, Young Adult, Cerebral Cortex metabolism, Cerebral Ventricles metabolism, Fatigue Syndrome, Chronic metabolism, Fatigue Syndrome, Chronic physiopathology, Glutathione metabolism, Lactic Acid metabolism, Oxidative Stress
- Abstract
Chronic fatigue syndrome (CFS) is a complex illness, which is often misdiagnosed as a psychiatric illness. In two previous reports, using (1)H MRSI, we found significantly higher levels of ventricular cerebrospinal fluid (CSF) lactate in patients with CFS relative to those with generalized anxiety disorder and healthy volunteers (HV), but not relative to those with major depressive disorder (MDD). In this third independent cross-sectional neuroimaging study, we investigated a pathophysiological model which postulated that elevations of CSF lactate in patients with CFS might be caused by increased oxidative stress, cerebral hypoperfusion and/or secondary mitochondrial dysfunction. Fifteen patients with CFS, 15 with MDD and 13 HVs were studied using the following modalities: (i) (1)H MRSI to measure CSF lactate; (ii) single-voxel (1)H MRS to measure levels of cortical glutathione (GSH) as a marker of antioxidant capacity; (iii) arterial spin labeling (ASL) MRI to measure regional cerebral blood flow (rCBF); and (iv) (31)P MRSI to measure brain high-energy phosphates as objective indices of mitochondrial dysfunction. We found elevated ventricular lactate and decreased GSH in patients with CFS and MDD relative to HVs. GSH did not differ significantly between the two patient groups. In addition, we found lower rCBF in the left anterior cingulate cortex and the right lingual gyrus in patients with CFS relative to HVs, but rCBF did not differ between those with CFS and MDD. We found no differences between the three groups in terms of any high-energy phosphate metabolites. In exploratory correlation analyses, we found that levels of ventricular lactate and cortical GSH were inversely correlated, and significantly associated with several key indices of physical health and disability. Collectively, the results of this third independent study support a pathophysiological model of CFS in which increased oxidative stress may play a key role in CFS etiopathophysiology., (Copyright © 2012 John Wiley & Sons, Ltd.)
- Published
- 2012
- Full Text
- View/download PDF
48. Responses to exercise differ for chronic fatigue syndrome patients with fibromyalgia.
- Author
-
Cook DB, Stegner AJ, Nagelkirk PR, Meyer JD, Togo F, and Natelson BH
- Subjects
- Adult, Analysis of Variance, Cardiography, Impedance, Case-Control Studies, Electrocardiography, Exercise Test, Fatigue Syndrome, Chronic physiopathology, Female, Humans, Male, Treatment Outcome, Exercise Therapy methods, Fatigue Syndrome, Chronic rehabilitation
- Abstract
Unlabelled: Chronic fatigue syndrome (CFS) and fibromyalgia (FM) are chronic multisymptom illnesses with substantial clinical and diagnostic overlap. We have previously shown that, when controlling for aerobic fitness and accounting for comorbid FM, CFS patients do not exhibit abnormal cardiorespiratory responses during maximal aerobic exercise compared with healthy controls, despite differences in pain and exertion., Purpose: The purpose of the present study was to examine cardiac and perceptual responses to steady-state submaximal exercise in CFS patients and healthy controls., Methods: Twenty-one CFS patients (13 CFS with comorbid FM (CFS + FM)) and 14 controls completed 20 min of submaximal cycling exercise. Impedance cardiography was used to determine cardiac responses during exercise. Systolic blood pressure (SBP), RPE, and leg muscle pain were also measured. Data were analyzed using a doubly multivariate, repeated-measures MANOVA to model the exercise response., Results: There was a significant multivariate time-by-group interaction (P < 0.05). The CFS + FM group exhibited an exercise response characterized by higher stroke index, ventilatory equivalents for oxygen and carbon dioxide and RPE, lower SBP, and similar HR responses compared to controls., Conclusions: The present results extend on our previous work with maximal exercise and show that CFS and CFS + FM differ in their responses to steady-state exercise. These results highlight the importance of accounting for comorbid conditions when conducting CFS research, particularly when examining psychophysiological responses to exercise.
- Published
- 2012
- Full Text
- View/download PDF
49. Sleep-stage dynamics in patients with chronic fatigue syndrome with or without fibromyalgia.
- Author
-
Kishi A, Natelson BH, Togo F, Struzik ZR, Rapoport DM, and Yamamoto Y
- Subjects
- Adult, Case-Control Studies, Fatigue Syndrome, Chronic physiopathology, Female, Fibromyalgia physiopathology, Humans, Polysomnography, Statistics, Nonparametric, Fatigue Syndrome, Chronic complications, Fibromyalgia complications, Sleep Stages physiology
- Abstract
Study Objectives: Chronic fatigue syndrome (CFS) and fibromyalgia (FM) are medically unexplained conditions that often have overlapping symptoms, including sleep-related complaints. However, differences between the 2 conditions have been reported, and we hypothesized that dynamic aspects of sleep would be different in the 2 groups of patients., Participants: Subjects were 26 healthy control subjects, 14 patients with CFS but without FM (CFS alone), and 12 patients with CFS and FM (CFS+FM)-all women., Measurements and Results: We studied transition probabilities and rates between sleep stages (waking, rapid eye movement [REM] sleep, stage 1 [S1], stage 2 [S2], and slow-wave sleep [SWS]) and duration distributions of each sleep stage. We found that the probability of transition from REM sleep to waking was significantly greater in subjects with CFS alone than in control subjects, which may be the specific sleep problem for people with CFS alone. Probabilities of (a) transitions from waking, REM sleep, and S1 to S2 and (b) those from SWS to waking and S1 were significantly greater in subjects with CFS+FM than in control subjects; in addition, rates of these transitions were also significantly increased in subjects with CFS+FM. Result (a) might indicate increased sleep pressure in subjects with CFS+FM whereas result (b) may be the specific sleep problem of subjects with CFS+FM. We also found that shorter durations of S2 sleep are specific to patients with CFS+FM, not to CFS alone., Conclusions: These results suggest that CFS and FM may be different illnesses associated with different problems of sleep regulation.
- Published
- 2011
- Full Text
- View/download PDF
50. Safety and efficacy of vagus nerve stimulation in fibromyalgia: a phase I/II proof of concept trial.
- Author
-
Lange G, Janal MN, Maniker A, Fitzgibbons J, Fobler M, Cook D, and Natelson BH
- Subjects
- Adult, Analgesia adverse effects, Analgesia instrumentation, Female, Fibromyalgia physiopathology, Follow-Up Studies, Humans, Middle Aged, Pilot Projects, Postoperative Complications epidemiology, Postoperative Complications physiopathology, Vagus Nerve Stimulation adverse effects, Vagus Nerve Stimulation instrumentation, Analgesia methods, Fibromyalgia therapy, Vagus Nerve Stimulation methods
- Abstract
Objective: We performed an open-label Phase I/II trial to evaluate the safety and tolerability of vagus nerve stimulation (VNS) in patients with treatment-resistant fibromyalgia (FM) as well as to determine preliminary measures of efficacy in these patients., Methods: Of 14 patients implanted with the VNS stimulator, 12 patients completed the initial 3-month study of VNS; 11 patients returned for follow-up visits 5, 8, and 11 months after start of stimulation. Therapeutic efficacy was assessed with a composite measure requiring improvement in pain, overall wellness, and physical function. Loss of both pain and tenderness criteria for the diagnosis of FM was added as a secondary outcome measure because of results found at the end of 3 months of stimulation., Results: Side effects were similar to those reported in patients treated with VNS for epilepsy or depression and, in addition, dry mouth and fatigue were reported. Two patients did not tolerate stimulation. At 3 months, five patients had attained efficacy criteria; of these, two patients no longer met widespread pain or tenderness criteria for the diagnosis of FM. The therapeutic effect seemed to increase over time in that additional participants attained both criteria at 11 months., Conclusions: Side effects and tolerability were similar to those found in disorders currently treated with VNS. Preliminary outcome measures suggested that VNS may be a useful adjunct treatment for FM patients resistant to conventional therapeutic management, but further research is required to better understand its actual role in the treatment of FM., (Wiley Periodicals, Inc.)
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.